These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 34638517)
1. The Cellular Prion Protein and the Hallmarks of Cancer. Mouillet-Richard S; Ghazi A; Laurent-Puig P Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638517 [TBL] [Abstract][Full Text] [Related]
2. The Cellular Prion Protein: A Promising Therapeutic Target for Cancer. Go G; Lee SH Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276687 [TBL] [Abstract][Full Text] [Related]
3. PrP(C) from stem cells to cancer. Martin-Lannerée S; Hirsch TZ; Hernandez-Rapp J; Halliez S; Vilotte JL; Launay JM; Mouillet-Richard S Front Cell Dev Biol; 2014; 2():55. PubMed ID: 25364760 [TBL] [Abstract][Full Text] [Related]
4. The Role of Cellular Prion Protein in Cancer Biology: A Potential Therapeutic Target. Ding M; Chen Y; Lang Y; Cui L Front Oncol; 2021; 11():742949. PubMed ID: 34595121 [TBL] [Abstract][Full Text] [Related]
5. An overview of transmissible spongiform encephalopathies. Takemura K; Kahdre M; Joseph D; Yousef A; Sreevatsan S Anim Health Res Rev; 2004 Dec; 5(2):103-24. PubMed ID: 15984319 [TBL] [Abstract][Full Text] [Related]
6. The cellular and pathologic prion protein. Gill AC; Castle AR Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138 [TBL] [Abstract][Full Text] [Related]
7. The Role of Cellular Prion Protein in Promoting Stemness and Differentiation in Cancer. Ryskalin L; Biagioni F; Busceti CL; Giambelluca MA; Morelli L; Frati A; Fornai F Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33418999 [TBL] [Abstract][Full Text] [Related]
8. The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases? Tian C; Dong X Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):429-34. PubMed ID: 23459557 [TBL] [Abstract][Full Text] [Related]
10. Synthetic prions and other human neurodegenerative proteinopathies. Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570 [TBL] [Abstract][Full Text] [Related]
11. Significance of prion and prion-like proteins in cancer development, progression and multi-drug resistance. Hinton C; Antony H; Hashimi SM; Munn A; Wei MQ Curr Cancer Drug Targets; 2013 Oct; 13(8):895-904. PubMed ID: 24015988 [TBL] [Abstract][Full Text] [Related]
12. Prion protein oligomer and its neurotoxicity. Huang P; Lian F; Wen Y; Guo C; Lin D Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632 [TBL] [Abstract][Full Text] [Related]
13. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases. Moreno JA; Telling GC Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793 [TBL] [Abstract][Full Text] [Related]
14. Role of proteomics in understanding prion infection. Campisi E; Cardone F; Graziano S; Galeno R; Pocchiari M Expert Rev Proteomics; 2012 Dec; 9(6):649-66. PubMed ID: 23256675 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and sequence analysis of prion protein gene in Xiji donkey in China. Zhang Z; Wang R; Xu L; Yuan F; Zhou X; Yang L; Yin X; Xu B; Zhao D Gene; 2013 Oct; 529(2):345-50. PubMed ID: 23954254 [TBL] [Abstract][Full Text] [Related]
16. [The non-conventional transmissible agents at the origin of transmissible subacute spongiform encephalopathies]. Dormont D Therapie; 1998; 53(2):93-100. PubMed ID: 9773107 [TBL] [Abstract][Full Text] [Related]